DF
AMLX icon

Dunhill Financial’s Amylyx Pharmaceuticals AMLX Stock Holding History

Dunhill Financial’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-600
Closed -$8.34K – 1637
2026
Q1 		$8.34K Hold
600
– – ﹤0.01% 555
2025
Q4 		$7.25K Hold
600
– – ﹤0.01% 547
2025
Q3 		$8.15K Hold
600
– – ﹤0.01% 503
2025
Q2 		$3.85K Hold
600
– – ﹤0.01% 583
2025
Q1 		$2.12K Hold
600
– – ﹤0.01% 720
2024
Q4 		$2.27K Hold
600
– – ﹤0.01% 698
2024
Q3 		$1.94K Buy
+600
New +$1.35K ﹤0.01% 717

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Dunhill Financial's AMLX Position: Q2 2026 in Review

Dunhill Financial sold out of Amylyx Pharmaceuticals (AMLX) in Q2 2026, closing a stake of 600 shares — an estimated $8.34K sold.

Dunhill Financial first reported a position in AMLX in Q3 2024 and held it in 7 quarters. The position peaked at $8.34K in Q1 2026. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Dunhill Financial reported no remaining Amylyx Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Dunhill Financial sold 600 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $8.34K.
  • Dunhill Financial first reported a position in Amylyx Pharmaceuticals in Q3 2024 and held it in 7 quarters.
  • Dunhill Financial's Amylyx Pharmaceuticals position peaked at $8.34K in Q1 2026.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.